Impact of L-carnitine and phosphatidylcholine containing products on the proatherogenic metabolite TMAO production and gut microbiome changes in patients with coronary artery disease
The aim of the study was to assess the impact of L-carnitine and phosphatidylcholine containing products on the production of the proatherogenic metabolite TMAO and gut microbiome changes in patients with coronary artery disease (CAD).
Material and methods. The study consisted of 2 parts. In the first part, a comparison was made between the diet of patients with CAD (n=29) and healthy volunteers (n=30) over the age of 50 with respect to the frequency of intake of L-carnitine and phosphatidylcholine containing products. All participants underwent blood sampling and stool tests to assess the concentration of TMAO and the composition of fecal microflora. The second part of the study was dedicated to assessing the correlation between TMAO blood concentration in patients with CAD (n=89) and the frequency of intake of L-carnitine and phosphatidylcholine containing products.
Results and discussion. Patients with CAD comparing to healthy people among the predecessor products of TMAO consumed red meat, dairy products more often, eggs and fish less often. TMAO concentration in patients with CAD was higher than in healthy volunteers (1036.4±748.2 vs 376.5±147.9 ng/ml, p=0.0001). Analysis of fecal microflora in patients with CAD revealed an increase number of bacteria from Verrucomicrobiaceae family (p<0.05) and Enterobacteriaceae family (p<0.05), of the Escherichia/Shigella genera (p<0.05), there was a trend to increased number of Ruminococcus (р=0.065), Clostridium XlV (b) genera (р=0.10). Correlation between TMAO concentration and frequency of red meat, eggs, and dairy products consumption was estimated in patients with CAD (r>0.525, р<0.05).
Conclusion. Patients with CAD consume more precursors of TMAO, have higher blood TMAO concentrations compared to healthy volunteers. Fecal microflora of patients with CAD contains a greater number of gut bacteria related to trimethylamine producers compared to healthy volunteers. Reducing the number of L-carnitine and phosphatidylcholine containing products in the diet of patients with CAD may affect the decrease in the proatherogenic metabolite TMAO concentration.
Keywords:cardiovascular disease, diet, coronary artery disease, trimethylamine-N-oxide (TMAO), intestinal microbiome
For citation: Ivashkin V.T., Kashukh Ye.A. Impact of L-carnitine and phosphatidylcholine containing products on the proatherogenic metabolite TMAO production and gut microbiome changes in patients with coronary artery disease. Voprosy pitaniia [Problems of Nutrition]. 2019; 88 (4): 25-33. doi: 10.24411/0042-8833-2019-10038 (in Russian)
1. World Health Organization. Global status report on noncommunicable diseases. 2014: 9-23.
2. Yu E., Malik V.S., Hu F.B. Cardiovascular Disease Prevention by Diet Modification: JACC Health Promotion Series. J Am Coll Cardiol. 2018; 72 (8): 914-26. doi: 10.1016/j.jacc.2018.02.085
3. Bowen K.J., Sullivan V.K., Kris-Etherton P.M., Petersen K.S. Nutrition and cardiovascular disease - an update. Curr Atheroscler Rep. 2018; 20 (2): 8. doi: 10.1007/s11883-018-0704-3
4. Wang Z., Klipfell E., Bennett B.J., Koeth R., Levison B.S. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011; 472: 57-63.
5. Kashukh Ye.A., Ivashkin V.T. Influence of human microbiome on the cardiovascular system. Molekulyarnaya Meditsina [Molecular Medicine]. 2017; 15 (4): 3-7. (in Russian)
6. Zhu W., Gregory J.C., Org E., Buffa J.A., Gupta N., Wang Z., et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016; 165 (1): 111-24. doi: 10.1016/ j.cell.2016.02.011
7. Al-Obaide M.A.I., Singh R., Datta P., Rewers-Felkins K.A., Salguero M.V., Al-Obaidi I., et al. Gut microbiota-dependent trimethylamine-N-oxide and serum biomarkers in patients with T2DM and advanced CKD. J Clin Med. 2017; 6 (9). pii: E86. doi: 10.3390/jcm6090086
8. Sun G., Yin Z., Liu N., Bian X., Yu R., Su X., et al. Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity. Biochem Biophys Res Commun. 2017; 493: 964-70. doi: 10.1016/j.bbrc.2017. 09.108
9. Chen K., Zheng X., Feng M., Li D., Zhang H. Gut microbiota-dependent metabolite trimethylamine N-oxide contributes to cardiac dysfunction in western diet-induced obese mice. Front Physiol. 2017; 8: 139. doi: 10.3389/fphys.2017.00139
10. Koeth R.A., Wang Z., Levison B.S., Buffa J.A., Org E., Sheehy B.T., et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013; 19: 576-85. doi: 10.1038/nm.3145
11. Boutagy N.E., Neilson A.P., Osterberg K.L., Smithson A.T., Englund T.R., Davy B.M., et al. Probiotic supplementation and tri-methylamine-N-oxide production following a high-fat diet. Obesity. 2015; 23: 2357-63. doi: 10.1002/oby.21212
12. Rohrmann S., Linseisen J., Allenspach M., von Eckardstein A., Muller D. Plasma concentrations of trimethylamine-N-oxide are directly associated with dairy food consumption and low-grade inflammation in a German adult population. J Nutr. 2016; 146 (2): 283-9. doi: 10.3945/jn.115.220103
13. Malinowska A.M., Szwengiel A., Chmurzynska A. Dietary, anthropometric, and biochemical factors influencing plasma choline, carnitine, trimethylamine, and trimethylamine-N-oxide concentrations. Int J Food Sci Nutr. 2017; 68 (4): 488-95. doi: 10.1080/09637486.2016.1256379
14. Jie Z., Xia H., Zhong S.L., Feng Q., Li S., Liang S., et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Com-mun. 2017; 8 (1): 845.
15. Rath S., Heidrich B., Pieper D.H., Vital M. Uncovering the trimethylamine-producing bacteria of the human gut microbiota. Microbiome. 2017; 5 (1): 54. doi: 10.1186/s40168-017-0271-9
16. Ishii C., Nakanishi Y., Murakami S., Nozu R., Ueno M., Hioki K., et al. A metabologenomic approach reveals changes in the intestinal environment of mice fed on American diet. Int J Mol Sci. 2018; 19 (12). doi: 10.3390/jms19124079
17. David L.A., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014; 505 (7484): 559-63. doi: 10.1038/nature12820
18. Janeiro M.H., Ramirez M.J., Milagro F.I., Martinez J.A., Solas M. Implication of trimethylamine N-Oxide (TMAO) in disease: potential biomarker or new therapeutic target. Nutrients. 2018; 10 (10). pii: E1398. doi: 10.3390/nu10101398